- Home
- AEI vs TRAW Comparison
AEI vs TRAW Comparison
Compare AEI & TRAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEI
- TRAW
- Stock Information
- Founded
- AEI 2014
- TRAW 1998
- Country
- AEI United States
- TRAW United States
- Employees
- AEI N/A
- TRAW N/A
- Industry
- AEI Building operators
- TRAW
- Sector
- AEI Real Estate
- TRAW
- Exchange
- AEI Nasdaq
- TRAW NYSE
- Market Cap
- AEI 8.8M
- TRAW 10.1M
- IPO Year
- AEI N/A
- TRAW 2013
- Fundamental
- Price
- AEI $0.93
- TRAW $1.54
- Analyst Decision
- AEI
- TRAW
- Analyst Count
- AEI 0
- TRAW 0
- Target Price
- AEI N/A
- TRAW N/A
- AVG Volume (30 Days)
- AEI 46.3K
- TRAW 55.1K
- Earning Date
- AEI 05-14-2025
- TRAW 05-14-2025
- Dividend Yield
- AEI N/A
- TRAW N/A
- EPS Growth
- AEI N/A
- TRAW N/A
- EPS
- AEI N/A
- TRAW N/A
- Revenue
- AEI $21,115,899.00
- TRAW $226,000.00
- Revenue This Year
- AEI N/A
- TRAW $3.81
- Revenue Next Year
- AEI N/A
- TRAW $30.43
- P/E Ratio
- AEI N/A
- TRAW N/A
- Revenue Growth
- AEI N/A
- TRAW N/A
- 52 Week Low
- AEI $0.46
- TRAW $1.52
- 52 Week High
- AEI $2.61
- TRAW $19.44
- Technical
- Relative Strength Index (RSI)
- AEI 52.82
- TRAW 26.40
- Support Level
- AEI $0.90
- TRAW $1.67
- Resistance Level
- AEI $1.00
- TRAW $2.63
- Average True Range (ATR)
- AEI 0.10
- TRAW 0.30
- MACD
- AEI 0.01
- TRAW 0.03
- Stochastic Oscillator
- AEI 69.60
- TRAW 0.84
About AEI Alset Inc. (TX)
Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.
About TRAW TRAWS PHARMA INC
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.